Lungenclinic Großhansdorf

Großhansdorf 22927

0 studies enrolling now · 4 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Non-Small-Cell Lung Carcinoma, Non-Squamous Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed